Structure |
Chemical Name |
CAS |
MF |
![Verapamil Related Compound B (4-[(3,4-Dimethoxyphenethyl)(methyl)amino]-2-(3,4-dimethoxyphenyl)-2-isopropylbutanenitrile hydrochloride)](/CAS/GIF/1794-55-4.gif) |
Verapamil Related Compound B (4-[(3,4-Dimethoxyphenethyl)(methyl)amino]-2-(3,4-dimethoxyphenyl)-2-isopropylbutanenitrile hydrochloride) |
1794-55-4 |
C26H37ClN2O4 |
 |
N-(5-(Propionyloxy)pentyl Acrylate) rac-trans-Laudanosine Benzenesulfonate |
155913-32-9 |
C38H49NO11S |
 |
1,8-ditosyl-1,4,8,11-tetraazacyclotetradecane dihydrochloride |
|
C24H38Cl2N4O4S2 |
 |
Mupirocin iMpurity 5 |
|
C26H44O9 |
 |
Tolvaptan Impurity 11 |
150683-27-5 |
C25H23ClN2O3 |
 |
methyl 2-(4-(2-chloroacetyl)phenyl)-2-methylpropanoate |
1638785-19-9 |
C13H15ClO3 |
 |
Fondaparinux sodium impurity 8 |
|
|
 |
Fondaparinux sodium impurity 14 |
|
|
 |
Fondaparinux Sodium Impurity 9 |
|
|
 |
Oxacillin sodium Impurity D |
|
|
 |
Piracetam IMPURITY |
|
|
 |
Nilotinib N-Oxide Impurity 4 |
|
|
![sodium (6R,7S)-7-amino-7-methoxy-6-methyl-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate](/) |
sodium (6R,7S)-7-amino-7-methoxy-6-methyl-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
 |
Olodaterol Impurity 32 |
|
|
 |
(R)-Lercanidipine Hydrochloride |
187731-34-6 |
C36H42ClN3O6 |
 |
2-Oxo Clopidogrel Hydrochloride(Mixture of diastereomers) |
109904-27-0 |
C16H16ClNO3S |
 |
5-ヒドロキシ-6-メトキシ-1-インダノン |
127399-78-4 |
C10H10O3 |
 |
Desfluoro Citalopram Oxalate |
1093072-86-6 |
C22H24N2O5 |
 |
Epalrestat iMpurity |
109801-00-5 |
C13H18O |
 |
5-Oxo Pitavastatin |
222306-15-2 |
C25H22FNO4 |
 |
(3R)-2,3-Dihydro-3-(2-propyn-1-ylaMino)-1H-inden-1-one |
1312077-05-6 |
C12H11NO |
 |
2-Hydroxy Cephalexin |
215172-75-1 |
C16H17N3O5S |
 |
3-(9H-Carbazol-4-yloxy)-1,2-propanediol |
123119-89-1 |
C15H15NO3 |
 |
4-(2-Methylpropoxy)-1,3-benzenedicarbothioaMide |
1330632-46-6 |
C12H16N2OS2 |
 |
9-MethoxyMethyl Guanine |
1202645-50-8 |
C7H9N5O2 |
 |
ClindaMycin 3-PalMitate |
68225-59-2 |
C34H63ClN2O6S |
![α,α'-Bis[(2-Methoxyphenoxy)Methyl]-1,4-piperazinediethanol](/CAS/GIF/333749-57-8.gif) |
α,α'-Bis[(2-Methoxyphenoxy)Methyl]-1,4-piperazinediethanol |
333749-57-8 |
C24H34N2O6 |
 |
Ticagrelor IMpurity E |
1402150-34-8 |
C26H30F2N6O5S |
![Benzenebutanoicacid,b-[[(1,1-diMethylethoxy)carbonyl]aMino]-2,4,5-trifluoro-,Methylester,(bR)-](/CAS/20150408/GIF/881995-73-9.gif) |
Benzenebutanoicacid,b-[[(1,1-diMethylethoxy)carbonyl]aMino]-2,4,5-trifluoro-,Methylester,(bR)- |
881995-73-9 |
C16H20F3NO4 |
![4-[(2,4-ジクロロ-5-メトキシフェニル)アミノ]-7-ヒドロキシ-6-メトキシ-3-キノリンカルボニトリル](/CAS/20200611/GIF/1460227-29-5.gif) |
4-[(2,4-ジクロロ-5-メトキシフェニル)アミノ]-7-ヒドロキシ-6-メトキシ-3-キノリンカルボニトリル |
1460227-29-5 |
C18H13Cl2N3O3 |
 |
Bisoprolol EP IMpurity B HeMifuMarate (Bisoprolol n-Propyl Derivative HeMifuMarate) |
1447715-44-7 |
C18H31NO4 |
 |
1155863-81-2 |
1155863-81-2 |
C23H19F2N3O6 |
 |
1175018-73-1 |
1175018-73-1 |
C12H14ClN |
 |
Clopidogrel Impurity 44 |
|
C15H14ClNO2S |
![5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate](/CAS/20200331/GIF/949155-13-9.gif) |
5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate |
949155-13-9 |
C20H22ClNO5 |
 |
Nifedipine impurity 06 |
|
C19H22N2O6 |
 |
Moxifloxacin Impurity 10 |
|
|
 |
Ticagrelor Impurity 11 |
|
|
 |
Parecoxib Impurity 18 |
|
|
 |
Teneligliptin Impurity 9 DiHCl |
|
|
 |
Pramipexole Impurity Z2 |
|
|
 |
1-Propanamine, 3-(diphenylphosphinyl)-N,N-dimethyl- |
962-95-8 |
C17H22NOP |
 |
Cabozantinib Impurity 50 |
202917-05-3 |
C17H14N2O5 |
 |
Landiolol impurity U |
|
|
 |
Didesmethyl Zolmitriptan |
139264-15-6 |
C14H17N3O2 |
 |
1-(カルボキシメチル)シクロヘキサン-1-カルボン酸 |
67950-95-2 |
C9H14O4 |
 |
ヒドロキシボセンタン |
253688-60-7 |
C27H29N5O7S |
![LISINOPRIL RELATED COMPOUND A ((S)-2-{(3S,8AS)-3-(4-AMINOBUTYL)-1,4-DIOXOHEXAHYDROPYRROLO[1,2-A]PYRAZIN-2(1H)-YL}-4-PHENYLBUTANOIC ACID)](/CAS/GIF/328385-86-0.gif) |
LISINOPRIL RELATED COMPOUND A ((S)-2-{(3S,8AS)-3-(4-AMINOBUTYL)-1,4-DIOXOHEXAHYDROPYRROLO[1,2-A]PYRAZIN-2(1H)-YL}-4-PHENYLBUTANOIC ACID) |
328385-86-0 |
C21H29N3O4 |
 |
trans 1-Benzyl-4-(4-fluorophenyl)-3-piperidinemethanol |
201855-60-9 |
C19H22FNO |
 |
1-エチル-4-オキソ-6-フルオロ-7-クロロ-1,4-ジヒドロキノリン-3-カルボン酸エチル |
70458-94-5 |
C14H13ClFNO3 |
 |
Capecitabine Related Compound B |
|
|
 |
D-erythro-3,4-Dihydroxyphenylserine |
51829-98-2 |
C9H11NO5 |
 |
aztreonam |
80951-91-3 |
C13H17N5O8S2 |
![5H-[1]Benzopyrano[2,3-b]pyridine,7-ethyl-(9CI)](/CAS/20200515/GIF/639857-68-4.gif) |
5H-[1]Benzopyrano[2,3-b]pyridine,7-ethyl-(9CI) |
639857-68-4 |
C14H13NO |
 |
Dabigatran iMpurity F |
1642853-67-5 |
C19H20N4O4 |
 |
Decitabine iMpurity 4 |
863396-35-4 |
C6H12O4 |
 |
Gliclazide iMpurity D |
1136426-19-1 |
C15H20N2O3S |
 |
Losartan IMpurity C (Isolosartan) |
114799-13-2 |
C22H23ClN6O |
 |
Posaconazole DiastereoisoMer interMediate 2 |
166583-12-6 |
C21H21F2N3O4S |
![Quetiapine IMpurity P (11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine fuMarate))](/CAS/20150408/GIF/1011758-03-4.gif) |
Quetiapine IMpurity P (11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine fuMarate)) |
1011758-03-4 |
C19H21N3S |
 |
TaMsulosin IMpurity B |
|
C20H28N2O5S |
 |
Ticagrelor iMpurity N |
|
|
 |
Tirofiban IMpurity (4,4'-Dipyridyl-1,5-Pentane) |
25382-33-6 |
C15H18N2 |
![3-Quinolinecarbonitrile,4-chloro-6-Methoxy-7-[3-(4-Methyl-1-piperazinyl)propoxy]-](/CAS/20150408/GIF/492444-39-0.gif) |
3-Quinolinecarbonitrile,4-chloro-6-Methoxy-7-[3-(4-Methyl-1-piperazinyl)propoxy]- |
492444-39-0 |
C19H23ClN4O2 |
 |
Vardenafil Oxopiperazine (IMpurity) |
448184-58-5 |
C21H26N6O5S |
 |
IverMectin B1 Aglycon |
73162-95-5 |
C34H50O8 |
 |
9α-BroMobudesonide |
313474-59-8 |
C25H33BrO6 |
 |
N-(5-Chloro-2-pyridinyl)-2-pyrazinecarboxaMide (Zopiclone IMpurity) |
349125-10-6 |
C10H7ClN4O |
 |
2-Methyl SiMvastatin (Mixture Of DiasteroisoMers) |
774611-54-0 |
C26H40O5 |
 |
(7R)-3-メチル-7-(ホルミルアミノ)セファム-3-エン-4-カルボン酸 |
184696-69-3 |
C8H8N2O3S |
![5,6-ジメトキシ-2-[(4-ピペリジル)メチル]インダン塩酸塩(DONEPEZIL IMPURITY)](/CAS/20150408/GIF/1034439-43-4.gif) |
5,6-ジメトキシ-2-[(4-ピペリジル)メチル]インダン塩酸塩(DONEPEZIL IMPURITY) |
1034439-43-4 |
C17H26ClNO2 |
 |
CarfilzoMib IMpurity |
1541171-65-6 |
C41H61N5O10S |
 |
BendaMustine IMpurity |
|
|
![D-Alanine, N-[[P(S),2'R]-2'-cyano-2'-deoxy-2'-Methyl-P-phenyl-5'-cytidylyl]-, 1-Methylethyl ester](/CAS/20180808/GIF/1496552-28-3.gif) |
D-Alanine, N-[[P(S),2'R]-2'-cyano-2'-deoxy-2'-Methyl-P-phenyl-5'-cytidylyl]-, 1-Methylethyl ester |
1496552-28-3 |
C22H29FN3O9P |
![D-Glucitol, 1,5-anhydro-1-C-[4-Methyl-3-[(5-phenyl-2-thienyl)Methyl]phenyl]-, (1S)-](/CAS/20180906/GIF/842133-16-8.gif) |
D-Glucitol, 1,5-anhydro-1-C-[4-Methyl-3-[(5-phenyl-2-thienyl)Methyl]phenyl]-, (1S)- |
842133-16-8 |
C24H26O5S |
![(alphaE)-alpha-[(3,4-Dihydroxy-5-nitrophenyl)methylene]-beta-oxo-1-piperidinepropanenitrile](/CAS/20150408/GIF/1150310-15-8.gif) |
(alphaE)-alpha-[(3,4-Dihydroxy-5-nitrophenyl)methylene]-beta-oxo-1-piperidinepropanenitrile |
1150310-15-8 |
C15H15N3O5 |
 |
(E)-N,N-ジエチル-2-シアノ-3-(3-エトキシ-4-ヒドロキシ-5-ニトロフェニル)アクリルアミド |
857629-79-9 |
C16H19N3O5 |
![(R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoate](/CAS/20150408/GIF/149709-59-1.gif) |
(R,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoate |
149709-59-1 |
C25H31NO4 |
 |
1-(3-アミノプロピル)-4-(2-メトキシフェニル)ピペラジン |
20529-23-1 |
C14H23N3O |
 |
(R)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
404874-94-8 |
C20H20FNO4 |
 |
(S)-3-((S)-5-hydroxy-5-phenylpentanoyl)-4-phenyloxazolidin-2-one |
|
C20H21NO4 |
 |
Posaconazole iMpurity 4 |
2125944-53-6 |
C30H35N5O3 |
 |
Everolimus Ring-Opening Impurity |
1708118-13-1 |
C53H83NO14 |
 |
Topiroxostat Impurity 6 |
2044704-63-2 |
C7H8N4O2 |
 |
Dienogest Impurity I |
65928-65-6 |
C20H27NO2 |
 |
Febuxostat Impurity 8 |
144060-62-8 |
C16H17NO4S |
 |
Lornoxicam Impurity 9 |
70374-36-6 |
C6H6ClNO4S2 |
 |
Ticagrelor Related Compound 3 |
88756-83-6 |
C8H15NO3 |
 |
Tadalafil EP Impurity |
479545-76-1 |
C21H16N2O5 |
 |
Vonoprazan Impurity C |
|
|
 |
(5RS)-5-Ethyl-2,6-diimino-5-phenyl-1,2,5,6-tetrahydropyrimidin-4(3H)-one |
69125-70-8 |
C12H14N4O |
![(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid](/CAS/20180629/GIF/1012341-54-6.gif) |
(2S,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-54-6 |
C23H29NO4 |
 |
3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzamide |
917391-28-7 |
C12H10F3N3O |
![Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl-](/CAS/20180629/GIF/132810-75-4.gif) |
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl- |
132810-75-4 |
C23H31N3 |
![(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one](/CAS/20180629/GIF/1839099-22-7.gif) |
(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one |
1839099-22-7 |
C25H26N6O2 |
 |
Linagliptin Impurity L |
|
|
 |
Sunitinib Impurity 4 |
|
|
 |
Tafluprost Impurity 11 |
|
|
 |
Tazobactam Impurity 4 |
|
|
 |
Propofol IMpurity E |
|
|